MTOR and nonpapillary renal cell carcinoma: In ccRCC, mutations were also found in several mTOR inhibitors, including PTEN (phosphatase and tensin homolog deleted from chromosome 10) and TSC1/2, highlighting the crucial impact of the mTOR signaling the development of ccRCC.